A. Sallmann

1.0k total citations
14 papers, 917 citations indexed

About

A. Sallmann is a scholar working on Pharmacology, Organic Chemistry and Pharmacology. According to data from OpenAlex, A. Sallmann has authored 14 papers receiving a total of 917 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 6 papers in Organic Chemistry and 4 papers in Pharmacology. Recurrent topics in A. Sallmann's work include Inflammatory mediators and NSAID effects (9 papers), Synthesis and Reactions of Organic Compounds (5 papers) and Pharmacogenetics and Drug Metabolism (3 papers). A. Sallmann is often cited by papers focused on Inflammatory mediators and NSAID effects (9 papers), Synthesis and Reactions of Organic Compounds (5 papers) and Pharmacogenetics and Drug Metabolism (3 papers). A. Sallmann collaborates with scholars based in Switzerland. A. Sallmann's co-authors include Irmgard Wiesenberg, Peter Moser, J. W. Faigle, H. Stierlin, R. Jaques, R. Menassé, P. R. Hedwall, W. Küng, H.‐P. KRIEMLER and W. J. Richter and has published in prestigious journals such as The American Journal of Medicine, Journal of Medicinal Chemistry and Cellular and Molecular Life Sciences.

In The Last Decade

A. Sallmann

14 papers receiving 837 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Sallmann Switzerland	9	394	222	151	147	144	14	917
J. W. Faigle Switzerland	19	372 0.9×	403 1.8×	202 1.3×	86 0.6×	251 1.7×	48	1.3k
James T. Doluisio United States	21	345 0.9×	156 0.7×	192 1.3×	115 0.8×	339 2.4×	53	1.4k
S. S. Adams United States	16	618 1.6×	352 1.6×	183 1.2×	166 1.1×	152 1.1×	25	1.4k
A. Sioufi Switzerland	23	273 0.7×	170 0.8×	351 2.3×	47 0.3×	196 1.4×	73	1.5k
Nobuo Inotsume Japan	17	185 0.5×	243 1.1×	120 0.8×	69 0.5×	221 1.5×	90	1.1k
Edwin T. Sugita United States	15	182 0.5×	79 0.4×	141 0.9×	94 0.6×	197 1.4×	42	813
Richard H. Reuning United States	15	133 0.3×	107 0.5×	143 0.9×	46 0.3×	136 0.9×	45	809
Joseph V. Swintosky United States	16	167 0.4×	120 0.5×	149 1.0×	115 0.8×	206 1.4×	71	1.1k
B. K. MARTIN United Kingdom	15	150 0.4×	218 1.0×	93 0.6×	46 0.3×	117 0.8×	35	673
J. Godbillon Switzerland	24	286 0.7×	188 0.8×	376 2.5×	31 0.2×	168 1.2×	61	1.3k

Countries citing papers authored by A. Sallmann

Since Specialization

Citations

This map shows the geographic impact of A. Sallmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Sallmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Sallmann more than expected).

Fields of papers citing papers by A. Sallmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Sallmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Sallmann. The network helps show where A. Sallmann may publish in the future.

Co-authorship network of co-authors of A. Sallmann

This figure shows the co-authorship network connecting the top 25 collaborators of A. Sallmann. A scholar is included among the top collaborators of A. Sallmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Sallmann. A. Sallmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Blum, W., J. W. Faigle, Ulrike Pfaar, & A. Sallmann. (1996). Characterization of a novel diclofenac metabolite in human urine by capillary gas chromatography-negative chemical ionization mass spectrometry. Journal of Chromatography B Biomedical Sciences and Applications. 685(2). 251–263. 29 indexed citations

Gerspacher, Marc, et al.. (1993). Strategies in the design of peptidoleukotriene antagonists.. PubMed. 6(1-3). 265–73. 5 indexed citations

Pfeilschifter, Josef, et al.. (1991). Pharmacological properties of five diclofenac metabolites identified in human plasma. Inflammation Research. 34(1-2). 135–137. 24 indexed citations

Sallmann, A., et al.. (1991). Peptidoleukotriene antagonists: Structural analogs of leukotriene D4 with special emphasis on CGP 45715A. Drugs of the Future. 16(9). 827–827. 14 indexed citations

Moser, Peter, A. Sallmann, & Irmgard Wiesenberg. (1990). Synthesis and quantitative structure-activity relationships of diclofenac analogs. Journal of Medicinal Chemistry. 33(9). 2358–2368. 146 indexed citations

Wenk, P., et al.. (1987). CGP 35949: a potent leukotriene antagonist and inhibitor of phospholipase. Biological profile.. PubMed. 17A. 526–31. 1 indexed citations

Sallmann, A.. (1986). The history of diclofenac. The American Journal of Medicine. 80(4). 29–33. 120 indexed citations

Sallmann, A.. (1985). The history of diclofenac. Seminars in Arthritis and Rheumatism. 15(2). 57–60. 8 indexed citations

Sallmann, A.. (1979). The chemistry of diclofenac sodium (Voltarol).. PubMed. Suppl 2. 4–10. 5 indexed citations

10.

Stierlin, H., J. W. Faigle, A. Sallmann, et al.. (1979). Biotransformation of diclofenac sodium (Voltaren®) in animals and in man. Xenobiotica. 9(10). 601–610. 162 indexed citations

11.

Rieß, W., H. Stierlin, P.H. Degen, et al.. (1978). Pharmacokinetics and Metabolism of the Anti-Inflammatory Agent Voltaren. Scandinavian Journal of Rheumatology. 7(sup22). 17–29. 166 indexed citations

12.

Menassé, R., et al.. (1978). Pharmacological Properties of Diclofenac Sodium and Its Metabolites. Scandinavian Journal of Rheumatology. 7(sup22). 5–16. 199 indexed citations

13.

Krupp, P., et al.. (1976). ChemInform Abstract: STRUCTURE‐ACTIVITY RELATIONS OF ANALOGS OF PHENYLBUTAZONE. Chemischer Informationsdienst. 7(15). 7 indexed citations

14.

Sallmann, A., et al.. (1973). Sodium [o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate (gp 45 840), a new non-steroidal anti-inflammatory agent. Cellular and Molecular Life Sciences. 29(4). 450–452. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact